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Missouri University of Science and Technology, Rolla, MO 
Abstract 
A major limitation of synthetic bone repair is insufficient vascularization of the interior 
region of the scaffold. In this study, we investigated the 3D printing of adipose derived 
mesenchymal stem cells (AD-MSCs) with polycaprolactone (PCL)/bioactive glass composite in 
a single process. This offered a three-dimensional environment for complex and dynamic 
interactions that govern the cell’s behavior in vivo. Borate based bioactive (13-93B3) glass of 
different concentrations (10 to 50 weight %) was added to a mixture of PCL and organic solvent 
to make an extrudable paste. AD-MSCs suspended in Matrigel was extruded as droplets using a 
second syringe. Scaffolds measuring 10x10x1 mm
3
 in overall dimensions with a filament width
of ~500 µm and pore sizes ranging from 100 to 200 µm were fabricated. Strut formability 
dependence on paste viscosity, scaffold integrity, and printing parameters for droplets of AD-
MSCs suspended in Matrigel were investigated. 
1. Introduction
Bone defects, resulting from trauma, cancer, arthritis, infection, or congenital skeletal 
abnormalities, contribute to major surgeries performed every year. Autologous bone graft is still 
considered as the golden standard for most applications but creates donor site morbidity [1, 2]. 
Allografts avoid these issues but have limited availability, concerns over immunogenicity, and 
potential disease transmission [3]. Several types of materials, including biocompatible metals, 
bioceramics, and biopolymers are currently being investigated as candidates for synthetic grafts. 
Additive manufacturing of these materials has shown that complex and strong implants can be 
made to treat different regions of bone, including load-bearing bone [4-6]. However, engineered 
bone scaffolds have not been as successful as autologous grafts due to insufficient 
vascularization and reduced biomechanical function [7, 8].
Borate based bioactive glasses are biocompatible, osteoconductive, and angiogenic. In 
comparison to the more common silicate based bioactive glass, such as 45S5 or 13-93 glass, 
bioactive borate glass (13-93B3) has a higher reaction rate (5-10 times faster than silicate 
glasses); is more resorbable (60 to 70% wt. loss) in a few days to weeks; and is angiogenic, 
antimicrobial, and osteo stimulatory/conductive [9]. Controlling the size of the glass particles 
means the degradation rate of the glass can also be controlled to some extent. With the bioactive 
glass, there is also the potential use of dopants that could increase the positive biological effects, 
such as angiogenesis. In comparison, hydroxyapatite resorbs slowly and undergoes little 
conversion to bone-like material after implantation and provides no flexibility to tailor the 
material properties for the application. Biocompatible polymers such as polycaprolactone (PCL), 
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provide strength and elasticity to scaffolds. PCL is one of the most widely used materials in 3D 
printing for biomedical applications because of its low cost and excellent rheological and 
viscoelastic properties [10]. Though PCL has a slow degradation rate (>2 years compared to few 
months for poly(lactic acid)/poly(glycolic acid) copolymers), a composite scaffold of 13-93B3 
and PCL may provide the benefits of both 13-93B3 glass and PCL materials. 
Mesenchymal stem / progenitor cells (MSCs) have been used for cell therapy and in 
tissue engineering because of their ability to differentiate into multiple mesenchymal lineages in 
vitro, immune modulatory effects, and angiogenic capacity [11, 12]. MSCs have been isolated 
from several tissues, including the bone marrow (BM-MSCs), adipose tissue (AD-MSCs), and 
skin tissue [13-16]. The frequency of MSCs in adipose tissue is much higher than the more 
commonly studied source of bone marrow, yielding 100 to 500 times more cells per tissue 
volume [17, 18]. AD-MSCs have similar self-renewal abilities, common surface epitopes, 
growth kinetics, and cytokine expression profiles to BM-MSCs. With the addition of MSCs, the 
scaffold is expected to improve its biomechanical and biological properties in order to better 
repair the target tissue. 
Recent research has focused on creating living or cell-laden grafts for tissue engineering 
[19-21]. In such techniques, cells or cell aggregates are dispersed, typically in a hydrogel, and 
then deposited layer-by-layer and solidified either by thermal or chemical processes to form a 
scaffold. Though such a scaffold holds promise in wound healing, drug delivery, and certain 
tissue engineering applications, bone repair requires a certain amount of mechanical integrity and 
controlled degradation of the scaffold which is difficult to accomplish. Traditionally, biopolymer 
scaffolds are fabricated using the fused deposition modeling process, where a polymer is melted 
and deposited thereby making it difficult to print cells alongside because of relatively high 
working temperatures [7]. In this study, we investigate the feasibility of printing a 3D scaffold 
using a two syringe system with a biopolymer/bioglass composite dissolved in an organic solvent 
as a scaffold material whilst simultaneously printing cells suspended in Matrigel, a gelatinous 
protein mixture representing basement membrane.    
2. Materials and Methods 
2.1 Preparation of PCL+bioactive glass composite 
PCL (Sigma-Aldrich, St. Louis, MO) was dissolved in chloroform (Sigma-Aldrich, St. 
Louis, MO) in a covered glass container with the help of a stirrer at ~50°C. The weight 
percentage of PCL was varied from 1:1 to 5:4 (grams of PCL to mL of chloroform) to determine 
the best possible ratio for printing. An appropriate ratio was established by visually inspecting 
the paste and through filament extrusion using a digital syringe dispenser. Then, 13-93B3 borate 
bioactive glass (Mo-Sci Corporation, Rolla, MO) (nominal composition – 53% B2O3, 20% CaO, 
12% K2O, 6% Na2O, 5% MgO, 4% P2O5 in weight percentage) of size less than ~20 µm was 
added to the PCL:chloroform mix in five different weight percentages in increments of 10, 
ranging from 10% to 50%. A magnetic stirrer was used to uniformly mix the composite paste 
and it was ensured that there was no glass particle precipitate before transferring the paste to a 
syringe. Each ratio was tested using a Loctite
®
 digital syringe dispenser (Henkel North America, 
Rocky Hill, CT) at air pressures ranging from 10 to 50 psi with nozzle tips ranging from 110 to 
500 µm. 
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 2.2 Scaffold fabrication 
The PCL/glass scaffold (10 mm x 10 mm) was printed with 0-90° orientation of the 
filaments in alternate layers, shown as schematic in Figure 1a. Printing was performed with an 
assembled DIY 3D printer (Geeetech, Prusa I3 A Pro) which was modified to have two syringes 
connected to digital syringe dispensers and are computer controlled. The 3D printer set-up is 
shown in Figure 1b. The printing parameters such as filament spacing, layer height, printing 
speed, etc. were identified based on visual inspection and optical microscopic images after a 
single layer extrusion. Printing parameters such as needle tip size (260 µm) and printing speed (~ 
8 mm/s) were uniform for all paste concentrations. Parameters such as air pressure and filament 
overlap are correspondingly modified for different pastes. Samples of 3D printed scaffolds were 
sputter coated with gold/palladium (Au/Pd) for 60 s before performing scanning electron 
microscopy (SEM). SEM (Hitachi S-4700 FESEM, Hitachi Co., Tokyo, Japan) images were 
taken to evaluate the surface morphology of scaffolds and internal structure of the filaments. 
 
Figure 1. (a) Schematic showing the fabrication of PCL+Bioglass filaments in 0-90 layer 
orientation with cells suspended in Matrigel (red dots), (b) 3D printer set-up with digital syringe 
dispensers  
2.3 Preparation and printing of AD-MSCs 
Different concentrations of Matrigel, diluted in phosphate buffered saline (PBS), ranging 
from 4 mg/mL to 10 mg/mL were printed using 10 psi and a 160 µm (30G) diameter nozzle tip 
to determine the ideal concentration for printing with cells. Frozen vials of approximately 1x10
6
 
AD-MSCs were obtained from three separate donors (LaCell, New Orleans, LA). Vials were 
unthawed, plated on 150 cm
2
 culture dishes (Nunc, Rochester, NY) in 25 mL complete culture 
media (CCM), and incubated at 37.5
o
C with 5% humidified CO2. After 24 hours, the media was 
removed and adherent, viable cells were washed twice with PBS, harvested with 0.25% trypsin/ 
1mM EDTA (Gibco), and replated at 100 cells/cm
2
 in CCM. Media was changed every 3 to 4 
days. For all experiments, sub-confluent cells (≤70% confluent) between passages 2 and 6 were 
used. 
After determining that a concentration of 9 mg/mL Matrigel yielded the preferred droplet 
size, AD-MSCs at a concentration of 1x10
6
 cells/mL were suspended in Matrigel. The printing 
parameters for Matrigel+cells were tested by designing a blocked experiment with air pressure as 
the blocked variable (10 and 20 psi). The other two variables considered were extrusion time 
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(0.025 s and 0.035 s) and distance from the substrate (100 µm and 200 µm). A sample size of n = 
3 was used for each droplet deposition with a specific set of parameters as shown in Table 1. 
When printing with Matrigel, the nozzle, cells, pipette tips, and Matrigel were all kept on ice 
until just before printing.  
Table 1. Experimental set-up to determine the Matrigel+cell droplet parameters (n = 3) 
Distance from substrate (µm) Dispensing time (s) Air pressure (psi) 
100 0.025 10 
200 0.025 10 
100 0.035 10 
200 0.035 10 
100 0.025 20 
200 0.025 20 
100 0.035 20 
200 0.035 20 
 
2.4 Degradation of PCL+bioactive glass and AD-MSCs distribution in Matrigel 
The degradation of the PCL/glass composite material was studied using a thin sheet of 
the composite prepared by pouring the PCL/glass mixture on a polished glass plate and tape 
casted using a doctor blade set at a thickness of 600 µm. The measured thickness of the dried 
film was 60±10 µm. Samples measuring 3 cm x 3 cm were cut from the sheet and kept in 50 mL 
of simulated body fluid (SBF) at 37°C. After the desired time intervals, the composite samples 
were removed from SBF and dried at 50°C for 12 h. The weight loss of each sample was 
measured and the SBF solution was analyzed by inductive coupled plasma spectroscopy (ICP) 
for boron, silicon, calcium, and phosphorus. To analyze the MSC distribution in Matrigel, 4',6-
diamidino-2-phenylindole (DAPI) stain was used to image the Matrigel+cell droplets using 
fluorescent microscopy.  
2.5 Effect of Chloroform Evaporation on AD-MSC Viability 
 The effect of chloroform evaporation from the scaffold on the viability of the AD-MSCs 
was studied by printing three layers of the 30% glass composite on a two chamber microscope 
slide (Thermo Fischer Scientific, Rochester, NY) then printing a layer of AD-MSCs at a 
concentration of 10x10
6
 cells per mL of Matrigel. The composite was printed according to the 
parameters given in Table 2 and the AD-MSCs were printed at 10 psi, 0.035 s dispensing time, 
and 200 µm from the slide. Four droplets of cells suspended in Matrigel, about 0.4 mm in 
diameter, were printed on each horizontal filament of the scaffold.  
 The Matrigel was allowed to polymerize at room temperature for 20 minutes then 1 mL 
of CCM was added. The slides were then incubated at 37.5
o
C with 5% humidified CO2. After 2 
hours, the cells were stained according to the directions given with life technologies 
LIVE/DEAD Cell Imaging Kit (ref. R37601, Eugene, OR) and examined under a fluorescent 





3. Results and Discussion 
3.1 Fabrication of PCL+bioactive glass composite 
 Single layer tests: The weight percentage of PCL was varied from 1:1 to 5:4 (in grams of 
PCL to mL of chloroform) to determine the best ratio for fabricating the scaffold. During the 
initial set of tests, different compositions of paste were extruded using a hand-held syringe and 
with the help of a digital dispenser by varying the nozzle tip and air pressure. An air pressure 
between 30 and 50 psi provided uniform extrusion of the PCL+chloroform mixture. The ideal 
ratio of PCL and chloroform was determined to be 5 g of PCL to 3 mL of chloroform, extruded 
at 30 psi using a 260 μm (25G) nozzle tip. A larger tip size (>260 µm) would result in thick 
filaments which are considered not beneficial for achieving faster scaffold degradation and 
smaller pore size distribution in the scaffold. Afterwards, 10% 13-93B3 glass by weight was 
added to the PCL+chloroform mixture and then extruded with the same set of parameters without 
difficulty. Figure 2a to 2c shows the filament extrusion tests performed on a microscopic glass 
slide with varying printing speeds. A reduced filament width (from 1.8 mm to 0.8 mm) can be 
observed with increasing table speed, which was tested from 3 to 10 mm/s. The filament width is 
also dependent upon the homogeneity of the mixture. Figure 2d shows a successful and 
continuous single layer of a 15 cm x 15 cm scaffold with the filament spacing of 0.7 mm and a 
printing speed of 8 mm/s. 
 
Figure 2. Single layer tests with (PCL+10% Glass) and different printing speeds (a) 3 mm/s, (b) 
5 mm/s, (c) 10 mm/s, and (d) 8 mm/s (which is used for rest of the experiments).  
Two layer tests: The filament height and spacing of the first layer would be crucial 
parameters to print successive layers. Filament height would determine the layer height and 
filament spacing would define how well the bridging occurs in successive layers. Figure 3a 
shows the optical microscopic image of the cross-sections of the first layer filaments. The 
average height of the filament (shown between the two arrows) was ~75 µm. The height of the 
filaments for 40 wt% and 50 wt% compositions remained the same as long as the same nozzle tip 
was used. The roundness of the filament improved with a smaller tip but because of the nozzle 
clogging issues, all the experiments were carried out with a 260 µm tip. Therefore, a layer height 
of 0.08 mm was used to fabricate subsequent scaffolds. Another important factor in this study is 
the dwell time between consecutive layers as this allows the chloroform to evaporate thereby 
allowing the previous layer to become dry. A longer dwell time (>5 min) would warp the layer 
and a shorter dwell time (<1 min) is not sufficient for the layer to dry. Figures 3b and 3c show 
the results of printing a second layer with no dwell time and with 1 min dwell time, respectively, 
with a 0.8 mm filament spacing. The difficulty in bridging the second layer without dwell time 
1.8 mm 
1.0 mm 0.8 mm 
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can be noticed, which was substantially improved with 1 mm dwell time. Figure 3d shows the 
bridging of second layer with 2.5 min of dwell time and 0.7 mm filament spacing. 
 
Figure 3. (a) Cross-sectional view of the PCL/glass filament measuring ~75 µm in height, (b) 
second layer printing with zero dwell time, (c) second layer printing with 1 min dwell time, and 
(d) second layer printed on top of the layer shown in Figure 2d with 2.5 min dwell time 
Multiple layer scaffolds: Based on the best printing parameters determined, scaffolds 
with multiple layers were fabricated with all five PCL/glass compositions (10 to 50 weight 
percentage of 13-93B3 glass). For compositions made with 40 wt% and 50 wt% glass, the 
amount of chloroform required to obtain a pourable characteristic for the paste was 4 mL 
(instead of 3 mL to 5 g of PCL). This is believed to be due to the increased viscosity of the paste 
with increase in glass content. With the exception of the paste made with 30 wt% of glass, which 
was extruded at an air pressure of 40 psi, remaining paste compositions were extruded at an air 
pressure of 30 psi. The final set of parameters used to fabricate scaffolds is given in Table 2. The 
filament width of 500±50 μm was measured for all compositions printed with a 260 µm nozzle 
tip while the average pore size depended on the filament spacing. A spacing of 0.6 mm provided 
pore sizes ranging from ~100 to ~200 μm while in scaffolds with a spacing of 0.7 mm, the pore 
size varied from ~200 to ~300 μm. Figure 4a shows an optical microscopic image of a scaffold 
fabricated with a filament spacing of 0.6 mm and with a smaller pore size distribution. As can be 
seen, pore sizes could be adjusted by modifying the filament spacing, to a certain extent, to suit a 
certain tissue engineering application of the fabricated scaffold. It is known that pore size is an 
important aspect of the scaffolds that could potentially effect the bone growth after implantation 
and it has been reported that pore sizes in the range of 100 to 300 µm are beneficial for bone 
growth [8]. The scaffolds fabricated by our process have pores in the same range. Figure 4b 
shows images of 10 mm x 10 mm scaffolds fabricated with 0.8 mm spacing. 






(g to mL) 
Filament Spacing 
(mm) 
10 30 5:3 0.6 – 0.8 
20 30 5:3 0.6 – 0.8 
30 40 5:3 0.6 – 0.8 
40 30 5:4 0.7 – 0.9 





Figure 4. (a) Optical microscopic image showing the pore size distribution (~150 µm) in a 
scaffold fabricated with 0.6 mm filament spacing, (b) (L-R) pictures of representative scaffolds 
made with 10% to 50% glass content; the bottom image shows the warpage of scaffolds 
containing 10 to 30 wt.% glass with the red arrow indicating the space between the scaffold and 
slide. No warpage is seen in 40% and 50% scaffolds; scaffold with 50 wt% glass is the thickest 
fabricated (1 mm). 
 It should be noted that the maximum thickness (or height) of the scaffolds depends on the 
degree of chloroform evaporation and the distance between layers. All of our experiments were 
carried out at room temperature (64°F) where the variation in relative humidity (58-60%) was 
not considered to be a major factor. Faster chloroform evaporation would produce warpage of 
the fabricated scaffold, especially with some dwell time between the layers. Non-uniform 
distribution of the PCL and glass is not believed to be one of the major factors of warpage as, 
upon examination of the filaments’ microstructure when printed with the same syringe at 
different time intervals, there was similar and uniform deposition of glass particles throughout 
the matrix. Therefore, the chloroform evaporation and the percentage of PCL in the composite is 
one of the crucial factors which determines the warpage. Increasing the glass content in the 
composite would indirectly decrease the chloroform content and thereby aids in faster 
evaporation and improves the filament rigidity. In this study, it was observed that after reaching 
a thickness of about 0.64 mm (8 layers), the scaffolds being fabricated with 10% and 20% glass 
exhibited warping which led to difficulty in printing successive layers (see Figure 4b). The 
warpage in scaffolds made with 30% and 40% glass was less pronounced and thickness of 0.8 
mm (10 layers) was obtained. The best results were achieved for 50% glass scaffolds as they 
were successfully printed to 1 mm thickness (12 layers) and could possibly have successive 
layers printed. Larger thicknesses were not attempted as the focus of this study is on the 
feasibility of printing PCL/glass scaffold along with MSCs. Though the mechanical properties of 
the scaffolds are not measured, it was observed that the ease of handling scaffolds improved with 
increasing glass content. The scaffold made with 50% glass had enough strength to be safely 
handled. 
Microstructure of PCL/glass composite scaffolds: Figure 5 shows the scanning electron 
micrographs of a couple of representative PCL/glass scaffolds made with 40 and 50 wt.% glass. 
Figures 5a to 5c show the surface morphology of the filament with increasing magnification 
(x30, x90, and x2000). It was interesting to observe that particles of bioglass are conspicuously 
absent from the surface of filaments. No pores on the filament surface were detected even when 
observed at a high magnification of x2000. Figures 5d to 5e show the filament fracture surface 
with increasing magnification (x180, x1000, and x2000). Glass particles dispersed in the PCL 
matrix can be seen in the interior. The dissolved PCL in chloroform encloses the glass particles 
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and the surface tension effects between the steel nozzle tip and PCL during extrusion might 
cause the presence of only PCL on the surface. 
 
Figure 5. SEM images of the PCL/glass scaffolds. (a-c) Images with increased magnification 
from L-R showing a smooth surface morphology of the filament (40% glass scaffold), (d-f) 
Images with increased magnification from L-R (50% glass scaffold) (d) showing the fracture 
surface, (e-f) porous cross-sectional area of the filament with PCL matrix and glass particles  
3.2 Degradation of PCL+bioactive glass composite in Simulate Body Fluid 
A “PCL+13-93B3 glass+chloroform” composite system has been studied in the recent 
past by producing thin sheets (60±10 µm) of PCL/glass composite [22]. The 3 cm x 3 cm sheet 
samples were soaked in SBF, dried overnight and weighed to measure their weight loss. The 
results indicate that 13-93B3 glass in the PCL/glass sheet had fully reacted to form 
hydroxyapatite (HA) in about 3 days. Figure 6 shows the weight loss percentages of the 
composite sheets made with different glass contents (20B – 20 wt.%, 40B – 40 wt.%, and 50B – 
50 wt.% of 13-93B3 glass). In all three composites, reaction of the borate glass occurred rapidly 
during the first three to six days and then weight loss remains nearly constant. As expected, there 
was no loss of weight after 14 days for PCL. Also, weight loss increases with the increasing 
weight percentage of borate glass. The arrows on the right axis indicate the ideal weight loss for 
each composite which is weight loss of the glass if it completely reacted in SBF to form 
stoichiometric HA (Ca10(PO4)6(OH)2). A similar degradation profile for 3D printed composite 




Figure 6. Weight loss for 50%, 40% and 20% glass compositions w.r.t weight loss of 100% PCL. 
The arrows on the right indicate the ideal weight loss for each composite [22]. 
3.3 Dispensing AD-MSCs suspended in Matrigel 
Experiments were conducted to print droplets of Dulbecco's Modified Eagle Medium 
(DMEM) which contained suspended AD-MSCs. It was determined that a 110 μm (32G) nozzle 
tip extruded droplets less than 500 µm suitable for printing either on top or alongside the 
deposited PCL/glass filaments. However, the DMEM in the printed droplets would evaporate 
quickly making it difficult for further investigation. Therefore, the option of using Matrigel as 
the medium to suspend the MSCs was considered. The initial set of experiments included 
dispensing the Matrigel droplets without cells with the syringe dispensing system set-up to 
determine an appropriate concentration of Matrigel and droplet size. A concentration of 10 
mg/mL Matrigel provided smaller drops (~100 μm), while 8 mg/mL Matrigel produced larger 
drops (~500 μm), and 4 mg/mL Matrigel produced even larger drops (1 mm). In each case, 
Matrigel provided a stable environment for the cells without drying (measured for up to 10 
minutes). As the filament width of the scaffolds was measured between 400 to 500 µm, a 
Matrigel concentration of 9 mg/mL was selected to be appropriate for generating droplets which 
could be deposited on top of the filaments. Approximately 1x10
6
 cells suspended in PBS were 
pipetted in Matrigel. The AD-MSCs+Matrigel solution was then transferred just before printing 
to a 160 μm nozzle tip which was stored on ice during the entire non-printing time. It is assumed 
that the MSCs were uniformly distributed in the Matrigel before the start of the droplet 
deposition. 
An experiment was conducted to dispense Matrigel droplets with suspended MSCs by 
varying parameters including distance of the nozzle tip from glass slide, dispensing time of 
droplet, and air pressure. ImageJ software was utilized to quantify the number of cells in each 
fluorescent image. Figure 6 shows DAPI stained images of Matrigel droplets with 1x10
6
 
cells/mL printed at different parameters. Figures 7a-7d show the fluorescent images of the 
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Matrigel droplets printed with 10 psi air pressure and Figures 7e-7h show the Matrigel droplet 
images printed with 20 psi air pressure. It can be clearly observed that droplets made at higher air 
pressure have a blue ring (cells are identified by blue dots in Figure 7) indicating that cells are at 
the boundary of the droplet because of the high pressure. This result is irrespective of the other 
two parameters. Droplets printed at the low air pressure (10 psi) have a smaller diameter and 
provide a more uniform distribution of cells. Such a distribution would be beneficial and the 
droplet size (<500 µm) would be appropriate to print on the PCL/glass filament. Among the four 
sets of droplets printed with 10 psi, it is observed that those printed with a distance offset of 200 
µm had more cells (150 and 153) in comparison to those printed with an offset of 100 µm (105 
and 148). Further, amongst the droplets printed with 200 µm offset distance and 10 psi pressure, 
the droplets printed with a pulse time of 0.035 s was measured to have slightly higher cell count 
(153) in comparison to those printed at 0.025 s (150). These results allow us to determine the 
printing parameters for depositing Matrigel droplets, which are: (i) air pressure of 10 psi, (ii) 
distance from glass slide of 200 µm, and (iii) pulse duration of 0.035 s. Figure 6a shows a 
Matrigel droplet printed with the above set of parameters. Select cells are marked using arrows 
for better comprehension of the image in print. Investigating the cell survivability on the 
“PCL+13-93B3 glass+chloroform” filament is a crucial step toward our goal of establishing a 




Figure 7. DAPI stained fluorescent images of AD-MSC/Matrigel droplets, printed at (a-d) 10 psi 
and (e-h) 20 psi air pressure. (a) A pulse time of 0.035 s and 200 µm distance from glass slide (b) 
0.025 s and 200 µm (c) 0.035 s and 100 µm (d) 0.025 s and 100 µm. The cells are at the 
boundary of the droplet because of higher air pressure. 
3.4 Effect of Chloroform Evaporation on AD-MSC Viability 
Viability of AD-MSC after printing was determined by a live/dead assay 2 and 24 hours 
after printing (Figure 8). At two hours, 96% were viable, demonstrating a minimal negative 
effect on the cells shortly after printing. At 24 hours, 65% were viable, indicating the potential 
for long term growth of the cells.  
 
Figure 8. Live/Dead images of AD-MSC/Matrigel droplets printed on 3 layers of the 30% 
glass PCL composite. Imaged after (a) 2 hours and (b) 24 hours. The yellow square indicates a 








This study investigated the feasibility of fabricating a scaffold with polycaprolactone 
(PCL) and 13-93B3 bioactive borate glass composite utilizing a 3D printer without any heat 
input. This method would allow the process to incorporate cells during the printing of a scaffold 
unlike other processes where heating of the biopolymer is involved. Scaffolds were printed and 
near optimal printing parameters for each of the five different PCL/glass compositions were 
determined. Scaffolds fabricated with a 50:50 (in weight percentage) PCL/glass composite 
utilizing the parameters of 30 psi, 5 g of PCL to 4 mL of chloroform, 0.8 mm filament spacing 
were easy to handle with sufficient mechanical integrity. Printing parameters for depositing cells 
suspended in Matrigel were determined and uniform distribution of cells in a ~400 µm droplet 
size was obtained for an air pressure of 10 psi and 0.035 s pulse. A live/dead assay performed 2 
and 24 hours after printing cells on a 3 layer scaffold showed minimal negative effects from 
chloroform evaporation on the cells. The results of this study show the potential of the process to 
fabricate a scaffold with living cells embedded for tissue engineering applications. 
A continuation of this study would include increasing the height of the scaffold. To 
achieve this, the scaffold fabrication process will be modified by avoiding the continuous 
printing of the single layer and incorporating start-stop operations to deposit each filament in the 
layer. Such an operation would avoid the excess build-up of material at the scaffold edge which 
aids in building thicker scaffolds. The objective of this study is to simultaneously print the MSCs 
and PCL+glass. Therefore, the viability of printing MSCs based on the height of the scaffold will 
also be investigated. The degradation of the PCL+glass scaffolds is a work in progress and 
despite its known hydrophobicity, the initial results indicate that DI water/cell culture media is 
able to penetrate PCL and helps in glass dissolution. In this context, it is believed that the 
fabricated scaffolds tend to be more porous than the designed porosity of ~50%. Further 
experiments will be performed to investigate the overall scaffold porosity. In relation to cell 
viability, a live/dead assay will be performed for 24 hours, 1 week, and 2 weeks with the 50% 
glass composition. 
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